Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
Open Access
- 11 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 69 (10), 1989-1999
- https://doi.org/10.1007/s00262-020-02593-w
Abstract
Despite recent advances in colorectal cancer (CRC) treatment, a large proportion of patients show limited responses to therapies, especially in advanced stages. There is an urgent need to identify prognostic biomarkers and/or therapeutic targets in advanced stages, aiming to improve the efficacy of current treatments. We aimed to determine prognostic biomarkers in tumor tissue and circulation of CRC patients, with a special focus on T cell exhaustion markers. We found that mRNA levels of PD-1, TIM-3, CTLA-4, TIGIT, CD160, CD244, KLRG1, TOX2, TOX3, Ki-67, and PRDM1 were elevated in CRC tumor tissues. We also investigated differences in gene expression between early and advanced disease stages. We found that TOX and potentially TIM-3, CTLA-4, VISTA, TIGIT, KLRG1, TOX2, SIRT1, Ki-67, and Helios mRNA levels in tumor tissue were elevated in advanced disease stages, suggesting their potential roles in CRC progression. In contrast, PD-1 and CD160 levels in tumor tissue were downregulated in advanced stages. In the circulation of CRC patients, mRNA levels of PD-1, VISTA and LAG-3 were higher than those of healthy individuals. Moreover, in circulation, PD-1, CTLA-4 and TIGIT mRNA levels were reduced in advanced stages. Interestingly, levels of PD-1 in both tumor tissue and circulation were reduced in advanced stages, suggesting that targeting PD-1 in patients with advanced stages could be less effective. Altogether, these findings suggest some potential T cell exhaustion markers that could be utilized as prognostic biomarkers and/or therapeutic targets for CRC. However, further investigations and validations in larger cohorts are required to confirm these findings.Keywords
Funding Information
- Qatar Foundation (VR04)
This publication has 46 references indexed in Scilit:
- Molecular and cellular insights into T cell exhaustionNature Reviews Immunology, 2015
- T-cell exhaustion in the tumor microenvironmentCell Death & Disease, 2015
- High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patientsScientific Reports, 2014
- Ki67 is a promising molecular target in the diagnosis of cancer (Review)Molecular Medicine Reports, 2014
- The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancerBMC Cancer, 2014
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug ResistanceMolecular Cell, 2014
- Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic InfectionImmunity, 2014
- Re-Evaluation of PD-1 Expression by T Cells as a Marker for Immune Exhaustion during SIV InfectionPLOS ONE, 2013
- Tumor budding in colorectal carcinoma: time to take noticeLaboratory Investigation, 2012
- Putting the brakes on BTLA in T cell–mediated cancer immunotherapyJCI Insight, 2010